Investing.com - Thermo Fisher Scientific (NYSE: TMO) reported fourth quarter EPS of $5.40, $0.18 better than the analyst estimate of $5.22. Revenue for the quarter came in at $11.45B versus the consensus estimate of $10.46B. Thermo Fisher Scientific sees FY 2023 EPS of versus the analyst consensus…
#eps #investingpro #financialhealth
Continue reading...